Market Overview

20 Healthcare Stocks Moving In Thursday's Pre-Market Session

Share:

Gainers

Tetraphase Pharmaceutical, Inc. (NASDAQ:TTPH) shares rose 49.82% to $2.03 during Thursday's pre-market session. According to the most recent rating by Gabelli & Co., on Mar 17, the current rating is at Sell.

Biomerica, Inc. (NASDAQ:BMRA) stock increased by 30.53% to $8.55.

Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) shares rose 24.34% to $0.87.

Evelo Biosciences, Inc. (NASDAQ:EVLO) shares rose 20.04% to $5.75.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares moved upwards by 18.47% to $0.34.

Sesen Bio, Inc. (NASDAQ:SESN) shares increased by 17.57% to $0.74.

AEterna Zentaris, Inc. (NASDAQ:AEZS) shares moved upwards by 13.86% to $1.15.

Livongo Health, Inc. (NASDAQ:LVGO) stock moved upwards by 12.76% to $52.95. The most recent rating by Needham, on May 7, is at Buy, with a price target of $55.

Conatus Pharmaceuticals, Inc. (NASDAQ:CNAT) stock moved upwards by 11.63% to $0.48.

Natera, Inc. (NASDAQ:NTRA) stock increased by 11.58% to $40. The most recent rating by JP Morgan, on May 7, is at Overweight, with a price target of $45.

 

Losers

Predictive Oncology, Inc. (NASDAQ:POAI) shares declined 13.33% to $1.30 during Thursday's pre-market session.

Macrogenics, Inc. (NASDAQ:MGNX) stock fell 9.18% to $22.84. The most recent rating by Credit Suisse, on May 6, is at Outperform, with a price target of $13.

ADMA Biologics, Inc. (NASDAQ:ADMA) shares fell 8.44% to $2.93. The most recent rating by H.C. Wainwright, on Mar 16, is at Buy, with a price target of $12.

Agile Therapeutics, Inc. (NASDAQ:AGRX) stock decreased by 6.50% to $2.30. The most recent rating by H.C. Wainwright, on Mar 20, is at Buy, with a price target of $6.

Bionano Genomics, Inc. (NASDAQ:BNGO) shares fell 6.21% to $0.34. The most recent rating by Oppenheimer, on Apr 8, is at Outperform, with a price target of $2.

Zafgen, Inc. (NASDAQ:ZFGN) stock fell 4.71% to $0.85.

Cellectis, Inc. (NASDAQ:CLLS) shares declined 4.64% to $13.78. The most recent rating by Goldman Sachs, on Mar 6, is at Sell, with a price target of $11.

Ritter Pharmaceuticals, Inc. (NASDAQ:RTTR) shares fell 4.50% to $0.42.

Axcella Health, Inc. (NASDAQ:AXLA) shares decreased by 4.42% to $5.40. The most recent rating by BTIG, on May 1, is at Buy, with a price target of $10.

KemPharm, Inc. (NASDAQ:KMPH) shares fell 4.35% to $0.25.

 

Related Articles (BMRA + TTPH)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas